Sir Michael Rudolf Stratton was born on 22 June 1957 and is a British clinical scientist and the third director of the Wellcome Trust Sanger Institute.
17 Facts About Michael Stratton
1.
2.
Michael Stratton currently heads the Cancer Genome Project and is a leader of the International Cancer Genome Consortium.
3.
Michael Stratton completed his clinical training at Guy's Hospital before training as a histopathologist at the Hammersmith and Maudsley Hospitals in London.
4.
Michael Stratton obtained a PhD while working on Medulloblastomas in the molecular biology of cancer at the Institute of Cancer Research, awarded by the University of London in 1990.
5.
Michael Stratton has held clinical posts at Guy's Hospital, Westminster Hospital, Hammersmith Hospital and the Royal Marsden Hospital.
6.
Michael Stratton took up a Faculty appointment and now holds a Professorship at the Institute of Cancer Research.
7.
Michael Stratton joined the Sanger Institute in 2000 and was promoted to deputy director in 2007.
8.
At the announcement of the completion of the Human Genome Project in 2000, Michael Stratton discussed using genome sequences to revolutionise cancer treatment.
9.
In 2002 and 2004, Michael Stratton's team discovered mutations in the BRAF and ERBB2 genes in approximately 60 per cent of malignant melanomas and 4 per cent of non-small-cell lung cancers respectively.
10.
Michael Stratton's team maintain the Catalogue of Somatic Mutations in Cancer database, a set of online resources available to the scientific community.
11.
Michael Stratton's research has been funded by the Wellcome Trust and the Medical Research Council.
12.
Michael Stratton was elected a Fellow of the Academy of Medical Sciences in 1999, elected a Fellow of the Royal Society in 2008, elected to EMBO Membership in 2009 and was awarded the Lila Gruber Cancer Research Award in 2010.
13.
Michael Stratton was knighted in the 2013 Birthday Honours for services to medical science.
14.
Michael Stratton is distinguished for his contributions to the genetics of human cancer.
15.
Michael Stratton's work has important implications for the understanding of the genetic mechanisms underlying cancer, diagnosis and therapy.
16.
In May 2022, Michael Stratton was awarded the inaugural 'In Search of Wonder Lifetime Achievement Award' at the Cambridge Independent's Science and Technology Awards, sponsored by Waterbeach creative design agency JDJ Creative.
17.
Michael Stratton received the award at a ceremony held at the Wellcome Genome Campus, just three months after announcing his decision to step down as director of the Wellcome Sanger Institute and CEO of the Wellcome Genome Campus after 12 years in the post.